Oklahoma ProCure Management, LLC: Company Profile

Background

Overview

Oklahoma ProCure Management, LLC, operating as ProCure Proton Therapy Center, was a specialized cancer treatment facility located in Oklahoma City, Oklahoma. The center focused on providing advanced proton therapy treatments, an innovative form of radiation therapy that minimizes damage to healthy tissues while effectively targeting cancer cells. ProCure was among the few independent proton therapy centers in the United States, offering a unique treatment option for patients.

Mission and Vision

ProCure's mission was to deliver cutting-edge cancer treatments through proton therapy, aiming to improve patient outcomes by reducing side effects associated with traditional radiation therapies. The vision was to establish a leading center for proton therapy, providing accessible and effective cancer care to the community.

Industry Significance

Proton therapy represents a significant advancement in cancer treatment, offering precision and reduced side effects compared to conventional radiation. As an independent center, ProCure played a crucial role in expanding access to this specialized treatment, contributing to the evolution of cancer care in the United States.

Key Strategic Focus

Core Objectives

ProCure's primary objective was to provide high-quality proton therapy treatments to cancer patients, ensuring precision and minimizing collateral damage to healthy tissues. The center aimed to be a leader in proton therapy, offering comprehensive care and support to patients throughout their treatment journey.

Areas of Specialization

The center specialized in proton therapy, focusing on its application across various types of cancer, including but not limited to brain, prostate, and pediatric cancers. ProCure was dedicated to advancing the use of proton therapy through clinical research and patient care.

Technologies Utilized

ProCure employed state-of-the-art proton therapy equipment, utilizing advanced imaging and treatment planning systems to deliver precise radiation doses. The center integrated cutting-edge technology to enhance treatment accuracy and patient safety.

Primary Markets Targeted

ProCure primarily served the Oklahoma City area, providing proton therapy services to patients seeking advanced cancer treatment options. The center also attracted patients from surrounding regions due to its specialized services.

Financials and Funding

Funding History

ProCure Proton Therapy Center faced financial challenges leading to a Chapter 11 bankruptcy filing in November 2018. The filing indicated estimated assets between $10 million and $50 million and liabilities ranging from $100 million to $500 million. The center intended to seek approval for debtor-in-possession (DIP) financing and pursue a sale of assets under Section 363 of the Bankruptcy Code.

Recent Funding Rounds

Specific details regarding recent funding rounds post-2018 are not publicly available. The bankruptcy proceedings and subsequent financial restructuring may have influenced the center's funding status.

Notable Investors

Information about individual investors or investment firms involved with ProCure is not publicly disclosed.

Utilization of Capital

The capital raised through DIP financing and asset sales was intended to support the center's operational needs, facilitate debt restructuring, and maintain the provision of proton therapy services to patients.

Pipeline Development

Key Pipeline Candidates

As a treatment center, ProCure did not develop pharmaceutical pipeline candidates. Instead, the focus was on providing proton therapy treatments to patients with various types of cancer.

Stages of Clinical Trials or Product Development

ProCure was not involved in conducting clinical trials or developing pharmaceutical products. The center's role was to deliver established proton therapy treatments to patients.

Target Conditions

The center treated a range of cancers, including brain, prostate, and pediatric cancers, utilizing proton therapy to target tumors with precision.

Timelines for Anticipated Milestones

Specific timelines for treatment milestones were individualized based on patient needs and treatment plans. The center aimed to provide timely and effective treatment to all patients.

Technological Platform and Innovation

Proprietary Technologies

ProCure utilized advanced proton therapy equipment and treatment planning systems, though specific proprietary technologies were not detailed in available sources.

Significant Scientific Methods

The center employed advanced imaging techniques and treatment planning methodologies to deliver precise proton therapy treatments.

AI-Driven Capabilities

There is no publicly available information indicating the use of AI-driven capabilities at ProCure.

Leadership Team

Key Executives

Specific details about the leadership team at ProCure are not publicly disclosed.

Professional Backgrounds

Information regarding the professional backgrounds of ProCure's leadership is not available.

Contributions or Roles

The leadership team was responsible for overseeing the center's operations, ensuring the delivery of high-quality proton therapy treatments, and navigating the financial restructuring process during the bankruptcy proceedings.

Leadership Changes

Recent Appointments

Details about recent leadership changes or appointments at ProCure are not publicly available.

Predecessor Roles and Dates

Information regarding predecessor roles and dates is not disclosed.

Competitor Profile

Market Insights and Dynamics

The proton therapy market is characterized by high capital investment and specialized technology requirements. Independent centers like ProCure face competition from larger hospital networks and other specialized treatment centers. Financial sustainability is a significant challenge due to the high costs associated with proton therapy equipment and operations.

Competitor Analysis

ProCure's primary competitors included other proton therapy centers and comprehensive cancer treatment facilities offering advanced radiation therapies. Specific competitor details are not provided in the available sources.

Strategic Collaborations and Partnerships

Information about strategic collaborations or partnerships involving ProCure is not publicly available.

Operational Insights

ProCure's operational strategy focused on providing specialized proton therapy treatments. The center's financial challenges, including the bankruptcy filing, highlight the operational difficulties faced by independent specialized treatment centers in maintaining financial viability.

Strategic Opportunities and Future Directions

Strategic Roadmap

Post-bankruptcy, ProCure's strategic focus would likely have been on restructuring operations, reducing debt, and stabilizing financial performance to continue offering proton therapy services.

Future Business Directions

Future directions would have involved enhancing treatment offerings, improving patient care, and potentially exploring partnerships to strengthen financial stability.

Opportunities for Expansion

Opportunities for expansion would have been contingent upon financial recovery and market demand for proton therapy services.

Positioning for Future Objectives

ProCure's ability to achieve future objectives would have depended on successful financial restructuring, operational efficiency, and maintaining a strong patient base.

Contact Information

Official Website

Specific contact details, including the official website, are not provided in the available sources.

Social Media Profiles

Information regarding ProCure's social media presence is not available.

Headquarters Location

Oklahoma City, Oklahoma, United States.